Acta Neuropathologica Communications Cellular and Molecular Neuroscience

Somatic TARDBP variants identified in human brain with FTLD-TDP-C disrupt morphology and microglia numbers in zebrafish

Leslie E. Sanderson, Ana Rajicic, Herma C. van der Linde, Merel O. Mol, Shamiram Melhem, Tahsin Stefan Barakat, Jeroen G. J. van Rooij, Tjakko J. van Ham, John C. van Swieten
Springer Nature · 2026-10-05 · DOI 10.1186/s40478-026-02417-5

Abstract

Abstract Pathogenic germline variants in TARDBP can cause amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Recently, we identified somatic TARDBP variants in the brains of two individuals with semantic dementia and FTLD-TDP type C pathology. These two somatic variants (L41F and R42H) were identified in the N-terminal domain of TARDBP , whereas the vast majority of functional studies so far have focused on C-terminal variants, in which other known pathogenic germline variants are located. We assessed the pathogenicity of the somatic N-terminal variants in vivo using zebrafish in direct comparison to germline TARDBP variants causing ALS and FTLD-TDP (P112H, K263E, and I383V). In line with in silico predictions, we show that somatic variant L41F is poorly tolerated in in vivo toxicity assays, resulting in a toxic gain-of-function when ubiquitously expressed. Furthermore, L41F showed substantial loss-of-function in rescue experiments performed in tardbp -deficient background. Germline variant K263E showed similar outcomes, while somatic variant R42H and germline variant I383V demonstrated lower levels of toxicity and loss-of-function in these assays. An increase in microglia was detected with overexpression of R42H mRNA compared to wild-type, indicating a potential immunogenic effect. Additionally, we created a novel germline N-terminal tardbp single amino acid deletion (G37del) in zebrafish, which caused severe morphological abnormalities. In conclusion, these data provide evidence of the pathogenicity of N-terminal variants, including L41F and R42H, found as somatic variants in FTLD-TDP C, and suggest that possibly germline variants in this domain may not be compatible with life. This might contribute to the absence of pathogenic N-terminal variants in patients, and further reinforces the importance of considering somatic contributions in FTLD-TDP.

Read at publisher →